| Status: Excluded due to NICE appraisal | |
Excluded due to NICE appraisal TA958: Ritlecitinib for treating severe alopecia areata in people 12 years and over |
|
Medicine details |
|
| Medicine name | Ritlecitinib |
| Formulation | oral |
| Reference number | 4270 |
| Indication | Treatment of moderate to severe alopecia areata in people 12 years and over |
| Company | Pfizer Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 09/01/2023 |
| NICE guidance | TA958: Ritlecitinib for treating severe alopecia areata in people 12 years and over |